News

10 Dec 2021
Aberdeen Frontier Markets - Incentivised to perform

QD view – Opportunities on the forefront(iers)

COVID-19 has monopolised headlines across all industries for the past two years, so you’d be forgiven for missing many other stories, especially those in already niche areas of the global investment market. But there are plenty of things to get excited about in the under-owned and under-represented frontier markets, which despite representing approximately 30% of […]

08 Dec 2021

QuotedData’s morning briefing 8 December 2021

In QuotedData’s morning briefing 8 December 2021: VH Global Sustainable Energy Opportunities (GSEO) has completed its acquisition of a second 10.9MW solar photovoltaic site located in Queensland, Australia. This acquisition completes the first tranche of this project consisting of two solar PV sites totalling 17MW as previously announced on 2 August 2021. Tranche II of […]

06 Dec 2021

India Capital Growth confirms upcoming redemption facility details and determines exit discount for 2023

India Capital Growth confirms upcoming redemption facility details and determines exit discount for 2023 – India Capital Growth, which is due to hold its redemption vote at the end of this year, has confirmed the arrangements for the vote, which will enable Shareholders to request redemption at an Exit Discount of 6%. In addition, and […]

06 Dec 2021

Barings Emerging EMEA Opportunities outperforms benchmark during recovery year

Barings Emerging EMEA Opportunities outperforms benchmark during recovery year – Barings Emerging EMEA Opportunities (BEMO) has published its full year results for the 12 months to 30 September 2021. During the period, the NAV total return was up 36.6% while its share price increased by 35.1%, compared to the benchmark return of +33.3%. The discount […]

06 Dec 2021

QuotedData’s morning briefing 6 December 2021

In QuotedData’s morning briefing 6 December 2021: Foresight Sustainable Forestry (FSF) has announced that Blackmead Forestry II, which FSF has an option to acquire, has fully completed the purchase of two substantial afforestation opportunities in Dumfries and Galloway, Scotland. Rorie Hill, one of the key afforestation opportunities, has a freehold area of 303 hectares and […]

01 Dec 2021

Chrysalis targets £125m in placing and PrimaryBid offer

Chrysalis targets £125m in placing and PrimaryBid offer – Chrysalis (CHRY) has announced plans to raise £125m under its placing programme, through a placing of ordinary shares at a price of 238 pence. The issue price represents a 1.7 per cent. premium to the pro forma NAV per ordinary share* as at 30 November 2021 […]

01 Dec 2021

VH Global Sustainable Energy Opportunities raises further £70m just nine months after launch

VH Global Sustainable Energy Opportunities raises further £70m just nine months after launch – VH Global Sustainable Energy Opportunities (GSEO) has raised a further £70m pursuant to the placing it announced on 8 November 2021. Accordingly, the company will issue a total of 68,965,518 New Ordinary Shares at the placing price of 101.5 pence per […]

01 Dec 2021

QuotedData’s morning briefing 1 December 2021

In QuotedData’s morning briefing 1 December 2021: Following the announcement on 3 November from BB Healthcare (BBH) that valid redemption requests in respect of 514,135 Ordinary Shares were received for the 30 November 2021 Redemption Point, the shares have been matched with buyers and sold at a calculated Redemption Price of 187.20 pence per share. It is […]

29 Nov 2021

End of Gresham House Strategic saga nears as board announces managed wind-down

End of Gresham House Strategic saga nears as board announces managed wind-down – Gresham House Strategic (GHS) has announced recommended proposals for managed wind-down of the company, proposed an initial return of capital and a return of capital by way of future tender offers and issued a notice for a requisitioned general meeting. This comes […]

29 Nov 2021

Syncona co-leads funding round for cell therapies developer

Syncona co-leads funding round for cell therapies developer – Syncona has committed $25m (£19m) to Quell Therapeutics in an up to $156m (£117m) Series B financing round as co-leader alongside specialist global institutional investors Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company. Following the Series B financing Syncona has […]